YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(2)
- Australia(8)
- Austria(3)
- Belgium(2)
- Brazil(1)
- Canada(94)
- China(20)
- Colombia(1)
- Denmark(3)
- Egypt(1)
- Finland(2)
- France(23)
- Georgia(1)
- Germany(52)
- Greece(1)
- Hong Kong(2)
- Hungary(2)
- India(104)
- Ireland(1)
- Israel(5)
- Italia (7)
- Japan(3)
- Luxembourg(1)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Norway(1)
- Pakistan(1)
- Peru(1)
- Poland(1)
- Portugal(4)
- Russia(1)
- Singapore(2)
- Slovenia(2)
- South Korea(3)
- Spain(13)
- Sri Lanka(1)
- Sweden(2)
- Switzerland(30)
- Taiwan(4)
- The Czech Republic(1)
- The Netherlands(4)
- Turkey(2)
- Ukraine(1)
- United Kingdom(87)
- United States(1030)
- Vietnam(1)
Contract Service Directory
Trial Runners
Company Headquarters
116 West Villard Street
Dickinson, ND 58601
United States
Other Locations
116 West Villard Street,
Dickinson, ND 58601
United States
Contract Service Directory
Related Content
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | CRO News | Industry News
Bioclinica Partners with Ikcon Pharma
Will work together to deliver best-in-class e-clinical solutions to the pharma industry & sponsors.Contract Pharma Staff 01.15.21
-
Clinical Trials | CRO News
Caprion-HistoGeneX Acquires Clinical Logistics
Expands its support of clinical trials specimen logistics.Contract Pharma Staff 01.08.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Breaking News | Clinical Trials | Promotions & Moves
Parexel Appoints Chief Patient Officer
Demonstrates the company’s commitment to elevating the patient perspective.Contract Pharma Staff 01.06.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
Breaking News | CRO News | Industry News | R&D
LINK Medical Acquires IRW Consulting AB
Strengthens its position in the Nordics while improving its offerings and capabilities.Contract Pharma Staff 12.09.20
-
Breaking News | Promotions & Moves
Frontida BioPharm Appoints Chief Financial Officer
Puneet Sapra brings 20 years of pharmaceutical and healthcare experience in executive roles at Pfizer, Johnson & Johnson, and Halma.Contract Pharma Staff 12.02.20
-
Bio News | Breaking News | Facilities | Industry News
Samsung Biologics Breaks Ground on 'Super Plant'
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.Contract Pharma Staff 11.24.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Breaking News | CRO News | Industry News
ACG Acquires Significant Stake in IQGEN-X
Enables IQGEN-X to fast-track research on existing ANDAs and set up another cGMP pilot facility.Contract Pharma Staff 11.05.20
-
Breaking News | CRO News | Facilities | Industry News | R&D
Reach Separations Expands Nottingham Premises
Responds to increased demand for its chiral purification services.Contract Pharma Staff 11.03.20
-
Breaking News
Syneos Health Agrees to Acquire Synteract
Enhances Syneos Health’s position across the fast-growing small to mid-sized category.Contract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | CRO News | Industry News
Reaction Biology and 4HF Biotec Collaborate
Announce new cell-based service offering that combines their technologies.Contract Pharma Staff 10.21.20
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Kristin Brooks, Contract Pharma 10.20.20
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
Breaking News | Collaborations & Alliances | CRO News
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
Will support new medical countermeasure research in the fight against emerging infectious disease.Contract Pharma Staff 10.08.20
-
Bio News | Breaking News | CRO News | Industry News
Kymos and Prolytic Merge
Become Kymos Group, a pan-European CRO dedicated to innovative pharmaceuticals.Contract Pharma Staff 09.28.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax
Will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose of JNJ-78436735 versus placebo.Contract Pharma Staff 09.23.20
-
Breaking News | CRO News
Europital Launches as Full Service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.Contract Pharma Staff 09.23.20
-
Breaking News | Trials & Filings
Laurent Pharma Initiates Phase II Trial of LAU-7b in COVID-19 Disease
LAU-7b has shown potent antiviral effects against SARS-CoV-2 and MERS-CoV coronaviruses, and is also being developed for its anti-inflammatory properties.Contract Pharma Staff 08.27.20
-
Clinical Trials | Drug Development
Beyond 2020: The Future of CROs
How will remote site access impact the CRO business?Ryan Jones, CEO, Florence Healthcare 08.21.20
-
-
Breaking News | Clinical Trials | Industry News
Roche’s Phase III Trial of Actemra in COVID-19 Misses Primary Endpoint
COVACTA trial did not meet primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoints.Contract Pharma Staff 07.30.20
-
PCI Pharma Services Announces Global Expansion of Clinical Trial Services
PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland Europe
-
-
Clinical Trials | CRO News | Trials & Filings
Lipidor, Cadila Sign Agreement for Phase III Trial of AKP-02
Cadila Pharmaceuticals to conduct a Phase III study for Lipidor's anti-psoriasis candidate AKP-02.Contract Pharma Staff 07.07.20
-
Breaking News | Clinical Trials
University of Oxford Selects Axiom eClinical Suite for Clinical Trial
Will focus on COVID-19 preventative treatments.Contract Pharma Staff 07.07.20
-
Biologics, Proteins, Vaccines | Breaking News
CureVac Receives Approval to Initiate Clinical Trial of SARS-CoV-2 Vaccine Candidate
First subjects will be vaccinated In Belgium and Germany.Contract Pharma Staff 06.17.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Aspargo Laboratories Completes Pre-IND Meeting with FDA
Collaborating with the CDMO Pii to develop and manufacture Sildenafil Oral Spray for clinical trialsContract Pharma Staff 06.08.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Ajinomoto Bio-Pharma Partners with Humanigen
Signs manufacturing agreement for Lenzilumab, a monoclonal antibodyContract Pharma Staff 05.27.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationKristin Brooks, Contract Pharma 05.18.20
-
Bioassay Development
QPS Announces COVID-19 Testing Capability
Developed a QPCR assay to identify active novel coronavirus infections.Contract Pharma Staff 05.13.20
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Supply Chain
Yourway and Firma Ink Clinical Supply Deal
Collaborate to administer coordinated supply delivery for home-health clinical trial visitsContract Pharma Staff 05.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Themis Collaborates with ABL Europe
ABL will manufacture Themis’ SARS-CoV-2 vaccine candidate in FranceContract Pharma Staff 05.12.20
-
Analytical Services | Breaking News | Risk Management
CluePoints Tech Benefits Clinical Studies Affected by COVID-19
Its COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies.Contact Pharma Staff 05.07.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Avid and Aragen Launch “Sequence-to-Manufacturing” Service
Designed to drive efficiencies and reduce overall timelines for delivering early-stage CGMP bulk drug substancesContract Pharma Staff 05.06.20
-
Breaking News | Industry News | Promotions & Moves
Cytovance Appoints VP of Biz Dev and Marketing
Mathew Delaney joins the senior leadership teamContract Pharma Staff 05.04.20
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
CRO Industry Update
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.Kristin Brooks, Contract Pharma 04.27.20
-
APIs | Breaking News | cGMP Manufacture | CRO News | Drug Development | Facilities | Industry News
Alcami Sells Netherlands Site to MerachemSyncom
Expands portfolio of chemistry services from compound design to clinical proof of concept.01.09.20
-
Analytical Services | Breaking News | CRO News | Industry News
Frontage Acquires CRO BRI
Expands geographic foothold into Canada and the West Coast of North America.01.03.20
-
Breaking News | CRO News | Facilities | Industry News
-
CRO News
Vivera Pharma, Parexel Ink Clinical Services Agreement
Parexel to conduct Phase I study to evaluate the bioavailability of TABMELT technology and provide regulatory support for Vivera's IND12.06.19
-
Analytical Services | Breaking News | CRO News | Industry News | Laboratory Testing | Microbiology
-
Frontage Laboratories' Hugh Davis
Frontage's chief business officer highlights the CRO's service offerings.Contract Pharma Staff
-
Breaking News | CRO News | Drug Development | Drug Discovery | Industry News | R&D
BASi Launches CRO Rebrand
Inotiv is the new name of its contract research services business.11.20.19
-
Biologics, Proteins, Vaccines | Clinical Trials
Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials
Overcoming the challenges of a new and changing clinical trial landscapeErin Finot, Global Head of Immuno-Oncology, IQVIA Biotech 11.18.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
BioDuro Chooses SciFinder-n From CAS
Enhances research productivity and shortens cycle times for clients.11.18.19
-
Bioanalytical Services
CMIC Details Services & Growth
Company executives Lucy Sha and Mike Suga spoke with Contract Pharma at AAPS 2018 about CMIC's history, growth & capabilities.Contract Pharma Staff
-
Bioanalytical Services | Breaking News | Industry News
BioAgilytix Acquires Cambridge Biomedical
Expands BioAgilytix’s global footprint into the Cambridge, MA biotech hub11.06.19
-
Clinical Trials | Drug Development | Promotions & Moves
AIT Bioscience Names New CEO
Jeff Goddard succeeds Terri Pascarelli, who has announced her retirement10.16.19
-
Clinical Trials | Drug Development
Contract Pharma’s 20th Anniversary Retrospective: Drug Development
A look back at the role of CROs in drug development and what we can expect for the futureKristin Brooks, Contract Pharma 10.16.19
-
Breaking News | CRO News | Industry News | Promotions & Moves
Pharm-Olam Appoints Robert Davie as CEO
Succeeds David Grange, positioning organization for continued growth10.15.19
-
Breaking News | Promotions & Moves
Experic Appoints Business Development Executive
Sherry Ann D’Iorio brings more than 20 years of experience in the CRO and life science industry.10.11.19
-
Clinical Trials | CRO News | Drug Development
NSF International Acquires Interest in Amarex CRO
Amarex will gain access to NSF’s network and international scale and will continue to operate from its U.S. office10.09.19
-
Breaking News | CRO News | Industry News
VIDEO: Frontage Laboratories' Hugh Davis
Frontage's chief business officer highlights the CRO's service offerings.10.09.19
-
Clinical Trials | CRO News | Information Technology
PRA’s Symphony Health Launches Metys
Aims to deliver accurate, reliable data quickly through a single access point09.19.19
-
Clinical Trials | CRO News | Drug Development
-
Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Industry News
CMIC Joins Align Clinical CRO
Will help develop open technology standards that streamline clinical trials07.17.19
-
Biologics, Proteins, Vaccines
Outsourcing in China: How far can it go?
China’s biopharmaceutical services market is on pace to top $1 billion by 2021Vicky Qing Xia, BioPlan Associates 07.15.19
-
Clinical Trials | Drug Development
Three Common Site Selection Mistakes
Initiating the wrong sites leads to recruiting the wrong patients and often results in failure to meet patient recruitment goalsKevin Vernarec, Senior Vice President and Global Head of Late Phase Clinical Development for QPS 07.12.19
-
Extractables and Leachables | Laboratory Testing
The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standardsKristin Brooks, Contract Pharma 07.11.19
-
Clinical Trials | GMPs/GCPs | QA/QC | Regulatory Affairs
Good Clinical Practice: Serious Breach Process
How to assess the significance of the breach, who needs to be involved, and how to report itJane Wood, Principal, YourEncore Quality Center of Excellence 06.27.19
-
Risk-Based Monitoring
Leveraging intelligent analytics to realize the full value of RBx and compliance with ICH E6 (R2)Richard Davies, Vice President, Solution Expert, CluePoints 06.13.19
-
Clinical Trials | CRO News
Quanticate Expands Presence in North America with New Toronto Office
The expansion, resulting from continued success and a year of growth across its key strategic partnerships, including top five pharmaceutical companies06.12.19
-
Breaking News | CRO News | Industry News
Research Point Global and WuXi CDS to Rebrand as WuXi Clinical
The newly combined CRO specializes in collaborative partnering for global clinical trials05.08.19
-
Information Technology
My Head is in The Cloud(s)
Cloud computing is making it easier to control all aspects of the global pharma production processEmil W. Ciurczak, DoraMaxx Consulting 05.07.19
-
PCI Clinical Services to Host Seminars
Topics will focus on phase I clinical trials in Australia at East Coast, U.S. locations05.01.19
-
Clinical Trials | Drug Development | Information Technology
Data Management in the Face of Growing Trial Complexity
Leveraging innovative processes and technology to help tackle the industry’s toughest data challengesRichard Young, Vice President, Veeva Vault EDC 04.22.19
-
Clinical Trial Materials
Clinical Manufacturing on Time and within Budget
The key to successful development and guiding a drug to approval is early planning.David Brett, Team Leader Product and Service Management, Vetter 04.05.19
-
APIs | Breaking News | Collaborations & Alliances | Industry News
-
Breaking News | Clinical Trials | CRO News | Information Technology
CRO Inks OmniComm EDC Agreement
Will use TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK03.15.19
-
2019 Trends & Predictions
Looking to the year ahead we discuss six key trends that will shape the industry.David Hukin and Thomas Underwood, QVigilance and Quanticate 03.06.19
-
Biologics, Proteins, Vaccines | Drug Development
Outsourcing & Emerging Biopharma
Richard Staub of IQVIA discusses the company’s new approach to providing clinical and commercial services for small biopharmaKristin Brooks, Contract Pharma 02.27.19
-
A Different Kind of CRO
Altasciences is a forward-thinking CRO for biopharma companies that recognize that time saved is opportunity gained, and opportunity gained is value realized.
-
Breaking News | CRO News | Industry News | Preclinical Outsourcing
-
Breaking News | CRO News | Industry News
Optimapharm Acquires Swiss CRO Denothex
Becomes a leading European mid-size clinical research organization02.07.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
QPS Expands Translational Medicine Division
Triples footprint of its Translational Medicine site in Newark, DE02.04.19
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News
Lambda to Acquire Novum
Novum will retain its identity and will operate as a division of global CRO leader Lambda Therapeutic Research giving Lambda entry into the U.S. market01.29.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
BioDuro and Advent Partner for Drug Discovery
Under the terms of the partnership, Advent has made an undisclosed majority investment in BioDuro01.28.19
-
Breaking News | Clinical Trials | CRO News | Industry News
QPS Expands U.S.-Based Phase I Clinical Trial Services
Supports growing needs of its pharmaceutical, biotech and CRO partners12.03.18
-
Analytical Services | Laboratory Testing
The Great Diaspora of the Pharma Industry
Or, good things come in small(er) packagesEmil W. Ciurczak, DoraMaxx Consulting 11.14.18
-
Breaking News | CRO News | Drug Development | Industry News
CMIC Details Services & Growth
Company executives Lucy Sha and Mike Suga spoke with Contract Pharma at AAPS 2018 about CMIC's history, growth & capabilities
-
Breaking News | Clinical Trials | CRO News
Rho Joins Avoca Quality Consortium
Gains access to AQC Knowledge Center with leading practices, guidelines, tools, and templates aimed at improving quality10.30.18
-
Global Outsourcing Strategies
As the market for outsourcing continues to grow, so too have the types of outsourcing models sponsors have to choose from.Colin Stanley, President, ICON Functional Services 09.11.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AMRI, Metrion Enter Drug Discovery Collaboration
Agreement enables customers to access a broader range of drug discovery expertise09.05.18
-
Bio News | Biologics, Proteins, Vaccines | CRO News | Industry News | R&D
Applied DNA Announces CRO & CMO Milestones
In the past year, Applied DNA has shipped over 8,000 milligrams of PCR-produced linear DNA for multiple applications08.02.18
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
LakePharma, Harbour Antibodies Form Discovery Partnership
Agreement provides access to H2L2 platform use with LakePharma's discovery and develop-ment services06.14.18
-
R&D
A Blueprint to Unify Clinical Operations
Fast-growing clinical research organization speeds study execution and improves qualityJim Reilly, VP of Clinical Market Strategy, Veeva Systems 05.08.18
-
Clinical Trials | CRO News | Information Technology
ICON, Intel Enter Pharma Analytics Platform Pact
ICON to offer the Intel Pharma Analytics Platform for use in clinical trials04.20.18
-
Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Accelovance, Linical Enter Merger
The merger agreement will allow both companies to deepen their oncology expertise04.03.18
-
Biologics, Proteins, Vaccines | Clinical Trials | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
BiondVax Enters Agreement with CRO
To conduct the first pivotal, clinical efficacy, Phase 3 trial of M-00103.13.18
-
Drug Development
Integrated Early-Stage Drug Development and Manufacturing
A key to accelerating the drug development process.Mark Egerton, Chief Executive Officer, Quotient Sciences 03.09.18
-
Analytical Services | Bioanalytical Services | Clinical Trials | CRO News | Industry News | Information Technology
Ora Adopts the Veeva Vault Clinical Suite
Enables Ora to combine CTMS, eTMF, and study start-up applications on one platform03.08.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News | Trials & Filings
Median Technologies, CMIC Holdings Collaborate
The partnership revolves around comprehensive clinical trial services03.01.18
-
CRO News | Promotions & Moves
Smithers Avanza Names New BD Director
Robert Moore to head up biz development efforts at the CRO02.06.18
-
Breaking News | CRO News | Drug Discovery | Industry News
Charles River Laboratories Buys KWS BioTest for $20M
Bolsters the CRO’s immunology contract research services01.12.18
-
CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Acquires KWS BioTest
Expands discovery services for immuno-oncology, inflammatory, and infectious diseases01.11.18
-
Clinical Trials | CRO News | Drug Development | Validation
-
R&D
CRO Consolidations: A Boon for Pharma?
In the contract research space there is a movement towards consolidation in order to expand capabilities and reach to serviceCraig Morgan, Head of Marketing, goBalto 11.07.17
-
Aseptic Processing | Injectables
Sterile Manufacturing: Future Trends and Challenges
By the middle of this century, biopharmaceuticals are set to overtake all other pharma salesIgor Gorsky, Concordia Valsource 10.11.17
-
Breaking News | Clinical Trials | Industry News
Quanticate Reinforces Global Offering with New Indian Office
Broadens capabilities for the management, analysis and reporting of clinical trial data09.27.17
-
Breaking News | CRO News | Facilities | Industry News
Clintec Expands UK HQ
CRO also presented with Queens Award for Enterprise – International Trade09.06.17
-
Clinical Trials | CRO News | Drug Development
-
CRO News | Drug Development | Drug Discovery | Information Technology
-
Clinical Trials | CRO News | Drug Development
-
APIs | Breaking News | Industry News
Olon SpA Acquires Part of Ricerca Biosciences
Strengthens service offering of global CDMO and generics provider for research and manufacturing06.13.17
-
R&D
Social Responsibility in Action
Transformation of strategic partnerships between CROs and sponsorsAndrew MacGarvey, CEO, CROS NT 06.06.17
-
Breaking News | Industry News
ShangPharma Restructures CRO and CMO Ops
Will consolidate all contract services under Shanghai ChemPartner04.04.17
-
Breaking News | CRO News | Industry News
TKL Research to Sell Clinical Trials Division
TKL’s existing Research Clinics Division will continue to operate as TKL Research, Inc.11.21.16
-
CRO-Sponsor Partnerships
10 tips for enabling better CRO and sponsor collaborationsCraig Morgan, Brand Development Director, goBalto Inc. 10.11.16
-
Breaking News | CRO News | Drug Development
Averica Discovery Expands Capabilities and Capacity
Enhances ability to supply early drug development programs06.03.16
-
Breaking News | CRO News
-
Clinical Trials | CRO News | R&D
Pharm-Olam Selected as CRO for Phase 2 Lymphoma Study
Infinity Pharma previously partnered with the CRO for another Phase II study03.01.16
-
Clinical Trials | Drug Development | R&D
-
Analytical Services | Promotions & Moves
Averica Appoints Cynthia Berger VP of Operations
Previously worked as project manager at PCI Synthesis01.21.16
-
Clinical Trials | Drug Development | Validation
-
Chemistry | Drug Development | Toxicology
Four Pillars to Guide Your CRO Search
Tips on how to seek out the best possible CRO-Sponsor relationshipAlan Findlater , WIL Research 11.17.15
-
CRO Actions for a Better IVR/IWR Implementation
Proactively preparing for IVR/IWR at an early stage will help your company reap significant benefits down the roadJonathan Cousins, Almac Clinical Technologies 09.11.15
-
Chemistry | Drug Discovery | Toxicology
CROs Are Making Headlines
India’s drug discovery service sector is heating upS. Harachand, Contributing Editor 09.11.15
-
Extractables and Leachables | Facilities | GMPs/GCPs | Inspections | Methods Development | Process Development | QA/QC | Regulatory Affairs | Validation
Emerging Hotbed of Surveillance Data?
Offshoring moves to Indian shores as regulations evolveS. Harachand, Contributing Editor 06.02.15
-
Clinical Trials
CRO Survey
CROs link the eTMF to better collaboration with sponsorsJennifer Goldsmith , Vice President, Vault Strategy, Veeva Systems 03.06.15
-
Chemistry | Clinical Trials | Drug Delivery | Drug Development | Drug Discovery | Formulation Development | Logistics | R&D | Supply Chain | Toxicology
Adoption of FTE Contracts in R&D Outsourcing: Present and Future
Pharma is looking for more R&D externalization for cost savings through FTE engagement.Sarabjeet Singh Sharad , Beroe Inc. 11.13.14
-
Breaking News | Drug Development | Drug Discovery | Industry News | Methods Development | Toxicology
Harlan CRS, Fluofarma Enter Strategic Discovery Pact
To employ Fluofarma discovery and translational services07.15.14
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Drug Discovery | GMPs/GCPs
Working With CRO’s: Lessons for Small Biotechs
Outsourcing increases flexibility, but sponsors need a clear strategy, from the start, if they want a synergistic partnershipJean Yarger , ENDECE, LLC 06.03.14
-
Clinical Trials | GMPs/GCPs | R&D
Sourcing Approaches for Clinical Development
Exploring models for R&DDaniel Chapple , Quanticate 04.03.14
-
-
Chemistry | Clinical Trials | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | GMPs/GCPs | Methods Development | Preclinical Outsourcing | Process Development | QA/QC | R&D | Toxicology | Validation
The Wild West of Basic Discovery
R&D outsourcing issuesNancy Gillett, Charles River Laboratories 11.13.13
-
Breaking News | Clinical Trials | CRO News | GMPs/GCPs
Alcobra Selects Premier Research for ADHD Study
Will conduct Phase III study of MG01CI in ADHD10.03.13
-
Hedge Your Bets
Inflation and foreign-currency considerations in pharma vendor contractsSamuel Mercer, Senior Outsourcing Manager 09.05.13
-
Breaking News | Promotions & Moves
Advanced Clinical Names Clinical Ops VP
Evans to lead strategic planning and tactile operations08.02.13
-
Breaking News | CRO News | Promotions & Moves
-
Drug Development | Validation | Vials
The Human Elements of a Successful Relationship
Best practices for outsourcing drug developmentWayland Rushing and Thomas J. Wilson, ABC Laboratories and Synta Pharmaceuticals 04.03.13
-
Drug Development
FSP Relationships
Developing alliances with CROsAndrew S. Townshend and Dr. Peter Carberry, INC Research and Astellas Pharma Global Development Inc. 03.06.13
-
CRO Strategic Partnerships
Benefits for small- and mid-sized biopharmaJosh Schultz, PAREXEL 03.06.13
-
Analytical Services | Bioanalytical Services | Bioassay Development | Breaking News | CRO News | Drug Development | Toxicology
-
Breaking News | Clinical Trials | CRO News | Drug Development | GMPs/GCPs
PPD to Complete OBI’s Oxycyte Trial
Will evaluate safety and tolerability in traumatic brain injury11.20.12
-
Breaking News | CRO News
-
Breaking News | Clinical Trials | CRO News | GMPs/GCPs
ICON Partners with Korea National Enterprise
Aims to advance clinical research in South Korea10.03.12
-
Breaking News | Promotions & Moves | Regulatory Affairs | Toxicology
Harlan Labs Expands Specialist Divisions
Hill and Henderson to head Agrochemicals and Pathology09.07.12
-
Breaking News | Clinical Trials | CRO News | GMPs/GCPs | Promotions & Moves
-
Bioassay Development | Clinical Trials | Drug Development | GMPs/GCPs | Information Technology | Methods Development | Preclinical Outsourcing | Process Development | R&D | Toxicology
Evolving Tactical Relationships Into Global Partnerships
Sponsor-CRO relationships in transitionAndrew Townshend and Ian Lauf, MBA, INC Research and Boehringer-Ingelheim 05.30.12
-
Clinical Trial Materials | Validation
-
Clinical Trial Materials
-
Clinical Trial Materials | Process Development | Validation
-
-
Breaking News | Clinical Trials | CRO News | GMPs/GCPs
-
Breaking News | Chemistry | Collaborations & Alliances | CRO News | Drug Discovery | Methods Development | Preclinical Outsourcing | Toxicology
-
Breaking News
-
Bioassay Development | Drug Development | Methods Development | Preclinical Outsourcing | Process Development | Toxicology
-
Breaking News | Clinical Trials | CRO News | Drug Discovery | GMPs/GCPs | Methods Development
Apricus Sells CRO Subsidiary
Apricus Biosciences has sold its specialty CRO subsidiary, Bio-Quant, Inc., to BioTox Sciences07.06.11
-
Breaking News | Promotions & Moves
ABC Labs Adds to CMC Team
Brad Benson, Ph.D., has joined the CMC Development Services team at ABC Laboratories.06.09.11
-
Breaking News | Industry News
Ricerca Sells Bothell Site to Numira
Ricerca Biosciences has sold its Bothell (West), WA in vivo operation to Numira Biosciences, a CRO specializing in high-resolution imaging and analysis of small animal specimens.02.15.11
-
Breaking News | Promotions & Moves
Advanced Clinical
Julie Heneghan has been appointed vice president of Advanced Clinical. Ms. Heneghan has more than 20 years of experience in the outsourcing and staffing solutions industry.09.02.10
-
Clinical Trials | Drug Development | R&D
-
Preclinical Outsourcing | Toxicology
Smart Sponsor Moves for 2010
Timely tips for successful outsourcing experiencesSteve Snyder 05.10.10
-
Breaking News | Chemistry | Drug Development | Industry News
PPD Launches Vax/Bio Center of Excellence
PPD, Inc. is launching the Vaccines & Biologics Center of Excellence, a network of integrated lab services focused on vaccine and biologic drug development.03.24.10
-
Breaking News | Drug Development | Promotions & Moves
Covance
Herman E. Scholtz, MD, has joined Covance as vice president and general manager of global clinical pharmacology services.12.10.09
-
Clinical Trials | Validation
EDC Focus: Making the Right Investment in CTMS/EDC
How to evaluate the solutionsJoseph J. Valeri 11.06.09
-
Drug Development | Preclinical Outsourcing | Toxicology
-
Chemistry | Excipients | Risk Management
Understanding Excipient Interfaces
Regulatory drivers for testing to better predict attributesAndrew Parker, Ph.D. 11.06.08
-
Breaking News | Promotions & Moves | Toxicology
-
Analytical Services | Bioanalytical Services | Breaking News | Clinical Trials | Industry News
-
Drug Development | Regulatory Affairs
Clinical Research Outsourcing
Moving from transactional to strategic partnership-based outsourcingKenneth Getz and Rachael Zuckerman 05.30.08
-
Drug Development | Logistics | Preclinical Outsourcing | Toxicology
-
Chemistry | Clinical Trials | Preclinical Outsourcing | Toxicology
-
Chemistry | Drug Development | Logistics | Toxicology | Validation
Bioanalytical Outsourcing
What factors affect outsourcing decisions?Anthony J. DeStefano and Stephen Lowes 11.09.07
-
Clinical Trials | Drug Development
Contracting Research: Criteria to Live By
How do we develop best practices for CRO partnerships?Jeffrey Steinberg and Karoline Dubiel 09.06.07
-
Breaking News | Promotions & Moves
-
Drug Development | Toxicology
Warning Signs?
Is there too much pressure in the preclinical drug development pipeline?Steve Snyder 04.02.07
-
Drug Development | Preclinical Outsourcing | Toxicology
-
Preclinical Outsourcing | Toxicology
-
Breaking News | Clinical Trials | Industry News
-
APIs | Chemistry | Drug Development | Drug Discovery | Inspections | Process Development | Supply Chain
Domestic Outsourcing for Drug Discovery
Guidelines for early-stage research issuesJeffrey M. Marra 09.13.06
-
Breaking News | Drug Discovery | Industry News
-
Chemistry | Clinical Trials | Drug Development | Drug Discovery
-
Drug Development | Inspections | Validation
Sponsor Expectations for Stability Programs
Some guidelines for sponsor inspectionsMargaret B. Voelz 08.22.05
-
Analytical Services | Bioanalytical Services | Clinical Trials | Drug Development | Drug Discovery
Outsourcing Drug Development
How to take advantage of a CROs experience and cultureDouglas J. Squires, Ph.D. 08.22.05
-
Chemistry | Clinical Trials | Drug Development | Toxicology | Validation
Managing CRO Selection
How will the rise of specialist intermediary organizations affect the process?David Cavalla, MA 08.22.05
-
Capsules | Drug Development | Extractables and Leachables | Facilities | Fill/Finish | Formulation Development | GMPs/GCPs | Lyophilization | Parenterals | Preclinical Outsourcing | Process Development | Process Validation | Scale-up/Technology Transfer | Solid Dosage/Semi-solids | Toxicology | Validation
Early Phase Outsourcing
A sponsor discusses the benefits of moving outsourcing earlier in the value chainAnthony De Stefano 08.22.05
-
Analytical Services | Bioanalytical Services | Bioassay Development | Cleaning Validation | Drug Development | Drug Discovery | Methods Development | Preclinical Outsourcing | Process Development | Process Validation | QA/QC | Toxicology | Validation
Full-Time Equivalent Agreements
An alternative strategy for long-term outsourcing of cGMP services.Thomas Wilson, Magdalena R. Mejilano 08.22.05
-
Clinical Trials | Drug Development
The CRO Industry: Opportunities and Trends
Global read, alliances and EDC continue to growKristin Brooks 06.21.05
